SCHEMBL22978619

SCHEMBL22978619

CCOc1cc(CCO)ncc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.37
CYP2D6 P10635 3/20 0.37
CYP2C19 P33261 3/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 3/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
AOC3 Q16853 1/20 0.35
RORC P51449 1/20 0.35
ENPP1 P22413 1/20 0.35
S1PR1 P21453 2/20 0.34
NPC1 O15118 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
S1PR3 Q99500 1/20 0.34
CNR2 P34972 2/20 0.34
AGPAT2 O15120 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22978481 0.80 S1PR1 (0.34) ALDH1A1HTTAOC3S1PR1S1PR3
SCHEMBL17894000 0.74 AOC3 (0.41) CYP1A2CYP2C19KDM4EALDH1A1LMNA
SCHEMBL29698385 0.74 AOC3 (0.41) CYP1A2CYP2C19KDM4EALDH1A1LMNA
SCHEMBL172311 0.73 AOC3 (0.40) CYP1A2CYP2D6CYP2C19KDM4EALDH1A1
SCHEMBL15527815 0.72 AOC3 (0.43) CYP1A2CYP2C19KDM4EALDH1A1LMNA
SCHEMBL10584255 0.70 NPC1 (0.40) KDM4EALDH1A1NPC1MAPTRAB9A
SCHEMBL22978620 0.70 CYP1A2 (0.38) CYP1A2CYP2D6CYP2C19KDM4EALDH1A1
SCHEMBL22980867 0.70 CYP3A4 (0.46) ALDH1A1LMNAHTTRORCCNR2
SCHEMBL17893983 0.70 CNR2 (0.44) LMNAHTTRORCCNR2
SCHEMBL29698237 0.70 CYP1A2 (0.38) CYP1A2CYP2D6CYP2C19KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021026672-A1 HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS NOVARTIS AG (CH) 2021-02-18 WO disclosed